Together, prolonged treatment with HGF + EGF mRNA-LNP leads to sustained and robust engraftment of functional PHHs, reduces the liver disease burden, and restores overall liver function in the clinically relevant p21/NSG-PiZ model. Here, EGF is linked to liver disorder.